M. Desjonquères

Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome

A. Belot, T. Henry, B. Py, 2018, Rheumatology.

Mycophenolate mofetil in juvenile dermatomyositis: a case series

B. Bader-Meunier, P. Quartier, R. Cimaz, 2012, Rheumatology International.

Tocilizumab in the treatment of mixed connective tissue disease and overlap syndrome in children

A. Belot, J. Lega, N. Fabien, 2016, RMD Open.

Pyrin dephosphorylation is sufficient to trigger inflammasome activation in familial Mediterranean fever patients

A. Belot, T. Henry, L. Waeckel, 2019, EMBO molecular medicine.

OP0136 Baseline Characteristics of Patients with Active Systemic JIA Successfully Discontinuing Corticosteroid while Receiving Canakinumab: Secondary Analysis from a Pivotal Phase 3 Trial

A. Martini, T. Constantin, J. Antón, 2013 .

MISS questionnaire in French version: a good tool for children and parents to assess methotrexate intolerance

A. Belot, É. Merlin, A. Duquesne, 2017, Clinical Rheumatology.

First report of rapidly progressive glomerulonephritis in tumor necrosis factor receptor-associated periodic syndrome.

B. Ranchin, R. Bouvier, C. Dodé, 2008, Arthritis and rheumatism.